FDA Inspection
Anna Kostera-Pruszczyk, MD, PhDAnna Kostera-Pruszczyk, MD, PhD – FDA Inspection, Jul 13, 2018
Record Details
This FDA Inspection record concerns Anna Kostera-Pruszczyk, MD, PhD, with an inspection on July 13, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 990897ab-490f-4f4e-a29e-b9aac799cdc4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1059483
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.